CTRP3 is a novel biomarker for diabetic retinopathy and inhibits HGHL-induced VCAM-1 expression in an AMPK-dependent manner. [electronic resource]
Producer: 20170928Description: e0178253 p. digitalISSN:- 1932-6203
- AMP-Activated Protein Kinases -- metabolism
- Biomarkers -- metabolism
- Case-Control Studies
- Cells, Cultured
- Collagen -- metabolism
- Diabetes Mellitus, Type 2 -- complications
- Diabetic Retinopathy -- diagnosis
- Endothelium, Vascular -- cytology
- Female
- Glucose -- adverse effects
- Humans
- Lipids -- adverse effects
- Male
- Middle Aged
- Retinal Vessels -- cytology
- Tumor Necrosis Factors -- metabolism
- Vascular Cell Adhesion Molecule-1 -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.